United States Interventional Oncology Devices Market Trends | Lucrative Opportunities for Investors 2032

DataM Intelligence has released an in-depth research report on "Interventional Oncology Devices Market Size 2025". This report delivers power-packed insights into key growth drivers, market segmentation, regional trends, CAGR forecasts, revenue performance of top players, and emerging opportunities. Gain a 360° market perspective with detailed analysis on value, volume, and future development trends your ultimate guide to spotting high-impact opportunities and staying ahead in this dynamic market.

In February 2025, IceCure Medical Ltd., a developer of minimally invasive cryoablation technology, sponsored the Breast Cryoablation Mini Masterclass at the 2025 Society of Interventional Oncology Annual Meeting in Las Vegas. The company provides a freezing-based tumor removal method as a less invasive alternative to surgery.

In July 2024, Techsomed Ltd. launched its FDA-cleared BioTrace software suite in the U.S., featuring Vision and Precision tools for liver tumor ablation across top medical centers.

In Nov 2024, Boston Scientific agreed to acquire Intera Oncology to expand liver cancer therapy solutions.

For instance, Japan's cancer prevalence is projected to rise by 13.1% by 2050, primarily due to a 13.6% increase in female survivors. From 2040 onwards, females will overtake males in prevalence counts. The most prevalent cancer sites in 2050 are colorectal, female breast, prostate, lung, and stomach cancers, accounting for 66.4% of survivors. Males are expected to experience the highest absolute increases in prostate, lung, and malignant lymphoma cancers, while females are expected to experience the highest absolute increases in breast, colorectal, and corpus uteri cancers.

Download Your Sample PDF Today and (Get Priority Access With a Corporate Email ID For Faster Delivery):- https://datamintelligence.com/download-sample/interventional-oncology-devices-market?kb

Industry Trends

In Dec 2024, AngioDynamics gained FDA 510(k) clearance for its NanoKnife System, offering a non-thermal, radiation-free prostate cancer treatment.

In Feb 2024, Profound Medical partnered with Siemens Healthineers to integrate the TULSA-PRO system with the MAGNETOM Free.Max MRI scanner, enhancing precision in prostate therapy.

List of Top Key Players:

Oncology Devices market include Medtronic, Boston Scientific, BD, Terumo, Merit Medical, AngioDynamics, Johnson & Johnson, Teleflex, Cook Medical, and HealthTronics, among others.

Forecast Growth Projection:

Global Interventional Oncology Devices Market Positioned for Strong Growth 2025-2032, Building on the steady momentum of 2024, the market is poised for remarkable expansion as leading players embrace innovative technologies and strategic advancements. This evolving landscape is unlocking lucrative opportunities for businesses to invest, scale, and stay ahead in an increasingly competitive and fast-moving market.

Market Research Process:

The Interventional Oncology Devices Market research report by DataM Intelligence combines extensive Primary and Secondary research to provide powerful, in-depth insights. It examines key market drivers such as regulatory frameworks, evolving market conditions, competitive dynamics, historical trends, and breakthrough technologies, while spotlighting emerging innovations and potential challenges. This all-inclusive analysis uncovers high-growth opportunities and highlights possible barriers, equipping businesses to tackle market volatility and capture new avenues for success.

Buy Now & Get Instant Access to 360° Market Intelligence:- https://www.datamintelligence.com/buy-now-page?report=interventional-oncology-devices-market

Market Segments:

Ablation devices to capture 42.8% market share

Global Growth Regions:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Opens the report with a comprehensive market overview, highlighting key segments by region, product type, and application. It presents a clear snapshot of market size, growth potential by segment, and both short- and long-term outlook.

Chapter 2: Showcases the most impactful insights, uncovering the emerging trends and disruptive forces shaping the industry's future.

Chapter 3: Delivers an in-depth competitive landscape analysis of the Interventional Oncology Devices market, covering revenue shares, strategic moves, and the latest mergers & acquisitions.

Chapter 4: Features detailed profiles of leading players, including their revenue streams, profit margins, product portfolios, and key milestones.

Chapters 5 & 6: Present a granular breakdown of regional and country-level revenue performance, offering a precise view of market size, opportunities, and development prospects worldwide.

Chapter 7: Analyzes market segmentation by product type, revealing the growth potential of each category and spotlighting high-impact.

Chapter 8: Examines application-based market growth, identifying the fastest-expanding sectors and lucrative opportunities for expansion.

Chapter 9: Maps the entire industry supply chain, providing insights into upstream and downstream activities for a complete market perspective.

Chapter 10: Concludes with key findings and actionable takeaways, guiding stakeholders toward strategic decisions and future growth opportunities.

Get Customization in the report as per your requirements:- https://datamintelligence.com/customize/interventional-oncology-devices-market?kb

Q1: How Large is the Interventional Oncology Devices Market?

A: The Interventional Oncology Devices Market was valued at US$ 2.70 Billion in 2024 and is expected to experience substantial growth, reaching US$ 5.00 Billion by 2033.

Q2: How fast is the Interventional Oncology Devices Market growing?

A: The Market is experiencing strong growth and is projected to expand at a CAGR of 7.1% from 2025 to 2032.

Q3: Which Region Leads Interventional Oncology Devices Market growth?

A: North America led with 42.3% share in 2024, while Asia-Pacific eyes 19.5% CAGR by 2033

Try DataM Subscription Services free for 2 days - Get Started@ https://www.datamintelligence.com/reports-subscription?kb

Make smarter moves with real-time competitor insights, strategic forecasts, and global investment trends-get it all now!

Access your Subscription Dashboard today@ https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.